Modernas

Moderna’s stock appears after Covid vaccine testing in children begins

Why Moderna’s stock grew today

Moderna’s shares may still be undervalued by 30%, says analyst

Why Moderna’s shares are falling today

Moderna’s new COVID-19 vaccine for the South African variant ready for human testing, says company

Why Moderna’s stock rebounded today

Moderna’s simple solution for vaccine supply: more doses in each vial

Why Moderna’s shares are falling today

Is Moderna’s stock a purchase or sale after Johnson & Johnson’s Vaccine News?

Moderna’s COVID-19 vaccine is now recommended for pregnant women, says WHO in reversal of orientation

Moderna’s shares are a type of investment “Buy and keep forever”

CDC: Moderna’s COVID-19 vaccine may cause allergic reaction in some people